Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
3.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
4.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
5.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
6.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
7.
Eye movement study in essential tremor patients and its clinical correlates.
J Neural Transm (Vienna)
; 130(4): 537-548, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894713
8.
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180218
9.
Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
Mov Disord
; 37(4): 826-841, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218056
10.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Mult Scler
; 28(9): 1424-1456, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196927
11.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
12.
Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes.
Alzheimer Dis Assoc Disord
; 36(1): 36-43, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001031
13.
Non-motor features of essential tremor with midline distribution.
Neurol Sci
; 43(10): 5917-5925, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849198
14.
Prevalence of Mood Disorders and Associated Factors at the Time of the COVID-19 Pandemic: Potocol for a Community Survey in La Manouba Governorate, Tunisia.
Clin Pract Epidemiol Ment Health
; 18: e174501792210250, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37274854
15.
Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis in a Tunisian Cohort.
Neuroophthalmology
; 46(4): 227-235, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859634
16.
Characterization of Recessive Parkinson Disease in a Large Multicenter Study.
Ann Neurol
; 88(4): 843-850, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045815
17.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
18.
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Brain
; 143(9): 2742-2756, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947619
19.
Early clinical markers of aggressive multiple sclerosis.
Brain
; 143(5): 1400-1413, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386427
20.
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19.
Neurol Sci
; 42(1): 39-46, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201360